{"id":20548,"date":"2023-07-21T20:30:00","date_gmt":"2023-07-21T20:30:00","guid":{"rendered":"https:\/\/www.prnasia.com\/story\/archive\/4163885_CN63885_0"},"modified":"2023-07-21T20:30:00","modified_gmt":"2023-07-21T20:30:00","slug":"ys-biopharma-to-report-financial-results-for-fiscal-year-2023-on-july-26-2023","status":"publish","type":"post","link":"https:\/\/transmediavictoria.net.au\/?p=20548","title":{"rendered":"YS Biopharma to Report Financial Results for Fiscal Year 2023 on July 26, 2023"},"content":{"rendered":"
\n\n\n\n
<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

GAITHERSBURG, Md.<\/span>, July 22, 2023 \/PRNewswire\/ — YS Biopharma Co., Ltd. (NASDAQ: YS) (“YS Biopharma” or the “Company”), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that it plans to release its financial results for the fiscal year ended March 31, 2023<\/span> after the U.S. market closes on Wednesday, July 26, 2023.<\/span><\/p>\n

The Company’s management will hold an earnings conference call at 8:00 P.M. Eastern Time on Wednesday, July 26, 2023<\/span> to discuss the financial results. Listeners may access the call by dialing the following numbers:<\/p>\n

\n\n\n\n\n\n\n\n
\n

United States Toll Free:<\/span><\/p>\n<\/td>\n

\n

1-888-346-8982<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

International:<\/span><\/p>\n<\/td>\n

\n

1-412-902-4272<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

Mainland China Toll Free:<\/span><\/p>\n<\/td>\n

\n

4001-201203<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

Canada Toll Free:<\/span><\/p>\n<\/td>\n

\n

18556699657<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

Hong Kong:<\/span><\/p>\n<\/td>\n

\n

852-301-84992<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n

Upon dialing-in, participants should ask to be joined into the YS Biopharma Co., Ltd. call.<\/p>\n

The replay will be accessible through August 2, 2023 by dialing the following numbers:<\/p>\n

\n\n\n\n\n\n\n
\n

United States Toll Free:<\/span><\/p>\n<\/td>\n

\n

1-877-344-7529<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

International:<\/span><\/p>\n<\/td>\n

\n

1-412-317-0088<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

Canada Toll Free:<\/span><\/p>\n<\/td>\n

\n

855-669-9658<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

Access Code:<\/span><\/p>\n<\/td>\n

\n

8524425<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n

A live and archived webcast of the conference call will also be available at the Company’s investor relations website at https:\/\/investor.ysbiopharm.com\/<\/a>.<\/p>\n

About YS Biopharma<\/b> <\/p>\n

YS Biopharma is a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA\u00ae<\/sup> immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. YS Biopharma operates in China, the United States, Singapore, and the Philippines<\/span>, and is led by a management team that combines rich local expertise and global experience in the biopharmaceutical industry. For more information, please visit investor.ysbiopharm.com<\/a>.<\/p>\n

Investor Relations Contact<\/b><\/p>\n

Robin Yang<\/span>
Partner, ICR, LLC
Tel: +1 (212) 537-4035
Email: YSBiopharma.IR@icrinc.com<\/a><\/p>\n<\/p><\/div>\n

Source: YS Biopharma Co., Ltd.<\/p>\n","protected":false},"excerpt":{"rendered":"

GAITHERSBURG, Md., July 22, 2023 \/PRNewswire\/ — YS Biopharma Co., Ltd. (NASDAQ: YS) (“YS Biopharma” or the “Company”), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that it plans to release its financial results for the fiscal year ended […]<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-20548","post","type-post","status-publish","format-standard","hentry","category-business-news"],"yoast_head":"\nYS Biopharma to Report Financial Results for Fiscal Year 2023 on July 26, 2023 - My Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/transmediavictoria.net.au\/?p=20548\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"YS Biopharma to Report Financial Results for Fiscal Year 2023 on July 26, 2023 - My Blog\" \/>\n<meta property=\"og:description\" content=\"GAITHERSBURG, Md., July 22, 2023 \/PRNewswire\/ — YS Biopharma Co., Ltd. (NASDAQ: YS) (“YS Biopharma” or the “Company”), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that it plans to release its financial results for the fiscal year ended […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/transmediavictoria.net.au\/?p=20548\" \/>\n<meta property=\"og:site_name\" content=\"My Blog\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-21T20:30:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnasia.com\/media2\/1911441\/YS_Biopharma_Logo.jpg?p=medium600\" \/>\n<meta name=\"author\" content=\"admin_tony\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin_tony\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=20548#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=20548\"},\"author\":{\"name\":\"admin_tony\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"headline\":\"YS Biopharma to Report Financial Results for Fiscal Year 2023 on July 26, 2023\",\"datePublished\":\"2023-07-21T20:30:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=20548\"},\"wordCount\":334,\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=20548#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/1911441\\\/YS_Biopharma_Logo.jpg?p=medium600\",\"articleSection\":[\"Business News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=20548\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=20548\",\"name\":\"YS Biopharma to Report Financial Results for Fiscal Year 2023 on July 26, 2023 - My Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=20548#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=20548#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/1911441\\\/YS_Biopharma_Logo.jpg?p=medium600\",\"datePublished\":\"2023-07-21T20:30:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=20548#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=20548\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=20548#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/1911441\\\/YS_Biopharma_Logo.jpg?p=medium600\",\"contentUrl\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/1911441\\\/YS_Biopharma_Logo.jpg?p=medium600\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=20548#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"YS Biopharma to Report Financial Results for Fiscal Year 2023 on July 26, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\",\"name\":\"My Blog\",\"description\":\"My WordPress Blog\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\",\"name\":\"admin_tony\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"caption\":\"admin_tony\"},\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?author=8\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"YS Biopharma to Report Financial Results for Fiscal Year 2023 on July 26, 2023 - My Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/transmediavictoria.net.au\/?p=20548","og_locale":"en_US","og_type":"article","og_title":"YS Biopharma to Report Financial Results for Fiscal Year 2023 on July 26, 2023 - My Blog","og_description":"GAITHERSBURG, Md., July 22, 2023 \/PRNewswire\/ — YS Biopharma Co., Ltd. (NASDAQ: YS) (“YS Biopharma” or the “Company”), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that it plans to release its financial results for the fiscal year ended […]","og_url":"https:\/\/transmediavictoria.net.au\/?p=20548","og_site_name":"My Blog","article_published_time":"2023-07-21T20:30:00+00:00","og_image":[{"url":"https:\/\/mma.prnasia.com\/media2\/1911441\/YS_Biopharma_Logo.jpg?p=medium600","type":"","width":"","height":""}],"author":"admin_tony","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin_tony","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/transmediavictoria.net.au\/?p=20548#article","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/?p=20548"},"author":{"name":"admin_tony","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"headline":"YS Biopharma to Report Financial Results for Fiscal Year 2023 on July 26, 2023","datePublished":"2023-07-21T20:30:00+00:00","mainEntityOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=20548"},"wordCount":334,"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=20548#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnasia.com\/media2\/1911441\/YS_Biopharma_Logo.jpg?p=medium600","articleSection":["Business News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/transmediavictoria.net.au\/?p=20548","url":"https:\/\/transmediavictoria.net.au\/?p=20548","name":"YS Biopharma to Report Financial Results for Fiscal Year 2023 on July 26, 2023 - My Blog","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/#website"},"primaryImageOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=20548#primaryimage"},"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=20548#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnasia.com\/media2\/1911441\/YS_Biopharma_Logo.jpg?p=medium600","datePublished":"2023-07-21T20:30:00+00:00","author":{"@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"breadcrumb":{"@id":"https:\/\/transmediavictoria.net.au\/?p=20548#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/transmediavictoria.net.au\/?p=20548"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/transmediavictoria.net.au\/?p=20548#primaryimage","url":"https:\/\/mma.prnasia.com\/media2\/1911441\/YS_Biopharma_Logo.jpg?p=medium600","contentUrl":"https:\/\/mma.prnasia.com\/media2\/1911441\/YS_Biopharma_Logo.jpg?p=medium600"},{"@type":"BreadcrumbList","@id":"https:\/\/transmediavictoria.net.au\/?p=20548#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/transmediavictoria.net.au\/"},{"@type":"ListItem","position":2,"name":"YS Biopharma to Report Financial Results for Fiscal Year 2023 on July 26, 2023"}]},{"@type":"WebSite","@id":"https:\/\/transmediavictoria.net.au\/#website","url":"https:\/\/transmediavictoria.net.au\/","name":"My Blog","description":"My WordPress Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/transmediavictoria.net.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7","name":"admin_tony","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","caption":"admin_tony"},"url":"https:\/\/transmediavictoria.net.au\/?author=8"}]}},"_links":{"self":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/20548","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=20548"}],"version-history":[{"count":0,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/20548\/revisions"}],"wp:attachment":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=20548"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=20548"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=20548"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}